clinical trial · NCT07019779
Study of CM518D1 in Patients With Advanced Solid Tumors
Keymed Biosciences Co.Ltd·phase2·recruiting·n = 434
Advanced Solid TumorsCM518D1CM518D1CM518D1
brief summary
This is an interventional study to assess the safety, tolerability, efficacy, pharmacokinetics, and immunogenicity of CM518D1 in patients with advanced solid tumors.
started
Jun 27, 2025
primary completion
Dec 31, 2028
completion
Dec 31, 2029
last updated
Nov 17, 2025
official title
A Multicenter, Open-Label, Phase I/II Clinical Study to Evaluate CM518D1 in the Treatment of Patients With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol